CS logo
small CS logo
Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia

Barcelona, Spain

About Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
12
Genentech, Inc.
1
Total Rows: 2

Clinical Trials at Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia


During the past decade, Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33223300331100001122Started TrialsCompleted Trails2017201820192020202101234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
2010-11-30
2020-09-10
Completed
799
A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke
2017-02-20
2017-11-03
Terminated
5
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
2017-06-27
2026-09-14
Active, not recruiting
316
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
2017-03-29
2019-06-11
Terminated
806
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease
2019-01-23
2022-03-17
Completed
899

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia" #1 collaborator was "Prothena Biosciences Limited" with 2 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 12Hoffmann-La Roche: 12Genentech, Inc.: 1Genentech, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsProthena Biosciences Limited: 2Prothena Biosciences Limited: 2Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1

Clinical Trials Conditions at Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia


According to Clinical.Site data, the most researched conditions in "Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia" are "Alzheimer's Disease" (3 trials), "Alzheimer Disease" (2 trials), "Generalized Myasthenia Gravis" (1 trials), "Huntington Disease" (1 trials) and "Huntingtons Disease" (1 trials). Many other conditions were trialed in "Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia" in a lesser frequency.

Clinical Trials Intervention Types at Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia


Most popular intervention types in "Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia" are "Drug" (13 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Gantenerumab" (3 trials), "Ocrelizumab" (2 trials), "Basmisanil" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia


The vast majority of trials in "Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia" are 13 trials for "All" genders.

Clinical Trials Status at Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia


Currently, there are NaN active trials in "Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 4Phase 2: 4

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 4Active, not recruiting: 4Completed: 4Completed: 4Terminated: 4Terminated: 4Recruiting: 1Recruiting: 1